Daily Stock List
Lexaria Corp. (LXRP)
PennyStocks24, SmallCapAllStars, TryBestPennyStocks.biz, OTPicks, Center Stage Stocks, OTCMagic, MarketWireStocks, fusionspicks, Stock Brain, and HEROSTOCKS reported recently on Lexaria Corp. (LXRP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Based in Kelowna, British Columbia, Lexaria Corp. is concentrating on becoming a trusted participant in the legal marijuana sector. The OTCQB-listed Company has been in business since 2005. It has also explored for and developed oil and gas assets in low-risk areas of North America. Lexaria still owns oil production in Mississippi, producing oil from wells at the Belmont Lake oil field. The Company looks for projects that could provide potential above-market returns.
Lexaria is focusing on the marijuana sector. This is the sector where it expects its major growth. Nonetheless, Lexaria has the above-mentioned valuable assets in the oil sector that generate revenue for the Company monthly. However, Lexaria is looking at entering the marijuana business in the U.S. and Canada. In essence, Lexaria is an aspiring Licensed Producer of medical marijuana under Canada's Marihuana for Medical Purposes (MMPR) program.
Lexaria reported in March of this year that its Board of Directors decided to make a strategic entry into the medical marijuana business via an important Joint Venture (JV) with Enertopia Corp. (ENRT). Mr. Robert McAllister, Chief Executive Officer and Chair of Enertopia, also agreed to join the Advisory Board of Lexaria, to evaluate and negotiate marijuana acquisitions and JVs. Enertopia is one of Canada's top medical marijuana companies. Enertopia has the capability of putting over 60,000 sq. ft. of production space into use in the cultivation of medical marijuana, by way of its partly owned subsidiaries.
Lexaria will not participate in Enertopia's pre-existing medical marijuana operations. Lexaria expects to use Enertopia's position as a recognized leader in the industry, to enter new agreements, which are accretive to Enertopia and Lexaria. The JV gives Enertopia the ability to share projects and opportunities with Lexaria, and a Right-Of-First-Refusal. The JV also allows for the two companies to work together on larger projects that might be out of reach of either company.
Recently, Lexaria announced that it submitted an application to become a Licensed Producer under Canada's MMPR program in July 2014. The Company is currently in the preliminary screening process. The Burlington Joint Venture has applied to produce up to 10,000 kilograms of medical marijuana annually under Canada's MMPR program. Enertopia has a 51 percent interest in the project. Lexaria has a 49 percent interest in the project.
Regarding oil wells, on September 16, 2014, Lexaria announced excellent oil production rates at its new PPF-12-7 oil well l at Belmont Lake, Mississippi. The well started producing roughly 120 bbl/d on a 12/64th choke. Lexaria retains a 42 percent working interest in the producing 12-1 and 12-3 wells, a 50 percent working interest in the suspended 12-4 and 12-5 wells, and a 13.3 percent working interest in the 12-7 well.
Lexaria Corp. (LXRP), closed Thursday's trading session at $0.0538, down 3.33%, on 61,900 volume with 9 trades. The average volume for the last 60 days is 82,964 and the stock's 52-week low/high is $0.0325/$0.785.
Aethlon Medical, Inc. (AEMD)
Clutch Investments, AllPennyStocks, Pennybuster, TopPennyStockMovers, SmallCapStockPlays, and StockBlogs reported on Aethlon Medical, Inc. (AEMD), and we choose to highlight the Company as well, here at the QualityStocks Daily Newsletter.
Aethlon Medical, Inc.'s mission is to create novel medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Company’s Aethlon ADAPT™ System (Adaptive Dialysis-Like Affinity Platform Technology) is a revenue-stage technology platform. This system provides the foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. OTCQB-listed Aethlon Medical has its corporate head office in San Diego, California.
Aethlon Medical announced, in September of 2013, the formal launch of Exosome Sciences, Inc. (ESI). This is the Company’s majority-owned subsidiary established by Aethlon to pursue exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease, and other life-threatening conditions.
The Aethlon ADAPT™ System is a medical device platform that joins single or multiple affinity drug agents with advanced plasma membrane technology. This is to create therapeutic filtration devices that selectively remove harmful particles from the entire circulatory system without the loss of essential blood components.
The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer. Aethlon Medical’s Aethlon Hemopurifier® is a first-in-class medical device with wide spectrum capabilities against viral pathogens. These include the human immunodeficiency virus (HIV), hepatitis C virus (HCV), and many bioterror and pandemic threats.
Aethlon Medical also has its ELLSA™ Exosome Assay. This is an enzyme-linked lectin-specific assay that has demonstrated the ability to identify and quantify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and all forms of cancer tested to date.
Moreover, its pipeline includes a medical device undergoing development under a five-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers (DARPA Sepsis Program). Aethlon additionally has its HER2osome™. It provides a therapeutic strategy to maximize the ability of the immune system and established drug therapies to combat HER2+ breast cancer.
Today, Aethlon Medical announced that officials at Frankfurt University Hospital reported undetectable virus in an ebola patient previously disclosed to have received Hemopurifier® therapy. In an article entitled: "Ugandan Doctor Cured of Ebola in Germany," The Wall Street Journal reported that hospital officials indicated the patient is no longer infected with ebola virus and is heading toward a full recovery.
Aethlon Medical Founder and Chief Executive Officer, Mr. Jim Joyce, stated "It is truly wonderful that the patient, who was reported to be suffering from multiple organ failure, is now recovering from ebola infection. In the coming days, we will disclose the venue of a public presentation that will report treatment data including the quantification of viral load reduction and viruses captured by our Hemopurifier during the treatment of this patient."
Aethlon Medical, Inc. (AEMD), closed Thursday's trading session at $0.251, up 9.18%, on 4,097,845 volume with 736 trades. The average volume for the last 60 days is 1,315,597 and the stock's 52-week low/high is $0.1025/$0.307.
Oro East Mining, Inc. (OROE)
InsidersLab, PennyStocksInsiders, StockMister, Penny Stock Circle, StockMarketQuote.us, Fortune Stock Alerts, 1-2-3 Stock Alerts, TheMicrocapNews, and SmallCapStockPlays reported recently on Oro East Mining, Inc. (OROE), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTC Bulletin Board-listed Oro East Mining, Inc. is a minerals development group. The Company is an exploration stage mining enterprise for the mining of gold, copper, and other precious or industrial mineral deposits. Oro East Mining’s current focus is in the State of California. The Company’s Board of Directors has decades of mining, mineral acquisition, and international trading experience. Oro East Mining is based in Oakland, California.
The Company’s mission is to revive the gold industry in the United States and merge advancing China-developed technology with U.S. mines in honour of Gold Mountain, a keystone of American Chinese history and legacy. Starting last year, Oro East Mining collaborated with partners in the West to establish the Company’s mining exploration and development in North and South America.
Oro East Mining’s projects include Carson Hill in the Sierra Foothills of California. This property is 900 acres. The Carson Hill Project is in its first stage of refinery processing. Through its subsidiary, Oro East Mining currently holds title to the leach pits (WMUs) and gold tailings. It has an option to purchase the Carson Hill claim in the entirety.
Its other project is the Red Bank Gold Mine in Mariposa County, California. This property is 55 acres. Via its subsidiary, Oro East Mariposa, LLC, Oro East Mining holds an exclusive rights, royalty agreement, and lease over the acreage in Mariposa, containing alluvial (placer) gold, gold bearing quartz veins, and other precious and semi-precious minerals. Its plan is to develop small-scale mining at Red Bank.
Oro East Mining completed shipment of 15 tons of gold concentrates to Royal Asset Management (RAM) on July 12, 2014. RAM remains one of Oroe’s top buyers. The RAM shipment marks an important milestone for the Carson Hill Gold Project. RAM is an Abu Dhabi based asset Management Company held by His Highness Shaikh Saqer Al Nahyan and royal family.
Recently, Oro East Mining and Guo Neng Rong Ding Beijing (the Scientific Development Co.), a Chinese corporation specializing in gold refining processing, started discussions in October regarding a joint venture between the parties. The terms of the discussion were put in a Letter of Intent (LOI). It proposed joint collaborative efforts in starting a new private corporation, which would build gold refining systems.
The systems and full scale gold refining production lines would be provided by Scientific Development and set up to process 3,000 tons of ore per day from stockpiles of ore concentrates at Carson Hill. The LOI reflects an agreement between the parties to work in good faith toward finalizing a contract by the end of this month.
Oro East Mining, Inc. (OROE), closed Thursday's trading session at $0.0501, up 8.91%, on 336,484 volume with 24 trades. The average volume for the last 60 days is 231,717 and the stock's 52-week low/high is $0.044/$2.36.
Mountain High Acquisitions Corp. (MYHI)
SmallCapVoice, Integrity Solution IR, Charms Investments LTD, FivedollarMovers.net, Wallstreet Profiler, and PennyDoctor reported on Mountain High Acquisitions Corp. (MYHI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mountain High Acquisitions Corp. is a strategic real estate holding company with corporate headquarters in Denver, Colorado. Its principal focus is the acquisition and development of commercial properties to be leased and used by the marijuana industry. At present, the Company’s portfolio includes three Colorado properties zoned for commercial marijuana cultivation: Isabelle, Madison, and Pueblo. Mountain High Acquisitions lists on the OTC Markets’ OTCQB.
The Company, via its wholly-owned subsidiary, Canna-Life Corp., is the current holder of purchase options on the three above-named real estate properties zoned by the State of Colorado and municipal authorities for the cultivation of marijuana. Mountain High’s focus is to serve the marijuana industry as a landlord providing value-added, state-of-the-art facilities and services. Mountain High does not and will not grow, harvest, distribute or sell cannabis or any substances that violate U.S. law or the Controlled Substances Act. The Company has no intention to do so in the future.
Mountain High Acquisitions’ tenants are licensed growers. The State of Colorado limits the number of commercial marijuana growers’ licenses. Consequently, the market of available tenants is tightly controlled and well understood. Currently, Mountain High believes existing demand from the licensed growers with whom it is in contact is more than adequate to fill any vacancy on its properties.
The Company announced earlier this year that Canna-Life completed the definitive Master Property Purchase and Sale Agreement for the acquisition of three properties and improvements located in Lafayette, Boulder County, Colorado, referred to as the Isabelle Property; Avondale, Pueblo County, Colorado, referred to as the Pueblo Property; and Denver, Denver County, Colorado, referred to as the Madison St. Property.
Mountain High earlier announced that it signed a Letter-of-Intent (LOI) to acquire property and related structures in Pueblo, Colorado. The 2.38 acre parcel of industrial land is beside the Pueblo Freeway. It has been zoned by the State of Colorado and municipal authorities for the cultivation of marijuana and preparation of marijuana related products.
In September, Mountain High announced that it completed all pre-closing due diligence pertaining to its previously announced LOI to acquire the 2.38 acre property and related structures in Pueblo, Colorado, known as the Greenhorn Property. The property presently holds a roughly 2,800 sq. ft. industrial use structure. It includes full grow rights for municipal water and a zoning allowance to build the whole footprint of the property two stories high with no set back.
Mountain High Acquisitions Corp. (MYHI), closed Thursday's trading session at $0.09, up 24.14%, on 163,500 volume with 10 trades. The average volume for the last 60 days is 33,415 and the stock's 52-week low/high is $0.054/$15.00.
╔nergie Holdings, Inc. (ELED)
Pumps and Dumps, VIP STOCK ALERTS, Stockhunter.us, Liquid Pennies, Stock Brain, and HEROSTOCKS reported earlier on ╔nergie Holdings, Inc. (ELED), and today we highlight the Company here at the QualityStocks Daily Newsletter.
Énergie Holdings, Inc.’s focus is on acquiring and growing companies that provide specialized light-emitting diode (LED) lighting solutions to the architecture and interior design markets. Its’ first wholly owned subsidiary, Énergie LLC, is now targeting the multi-billion dollar architectural, specification-grade lighting fixture segment of the North American lighting fixture market with pioneering, differentiated LED lighting products. OTCQB-listed Énergie Holdings has its headquarters in Wheat Ridge, Colorado. Its subsidiary, Énergie LLC, has facilities in Zeeland, Michigan.
Énergie Holdings has a large installed base of customers in all 50 States and Canada. Énergie' LLC is based upon partnerships with different European suppliers of innovative highly efficient LED lighting technology. Énergie maintains exclusive, contractual relationships with five leading European and one Taiwanese manufacturer. No other company can sell the products the Company represents in North America.
Énergie Holdings has access to all patents, copyrights, and trademarks of its partners and owns the UL/CUL listings for each product it sells. As these partners are continually developing new products, Énergie has the first right to launch these products in the North American marketplace.
The strategy of the Énergie LLC subsidiary is to enter into exclusive sales agreements with European suppliers that have unique lighting products. In addition, its strategy is to bridge the divide between North American architects' and designers' desired access to innovative European products and European manufacturers' desire to find a cost effective way to penetrate the North American markets for their products.
Énergie Holdings is continuing to identify and acquire other companies that have proven expertise in LED technology. Targets include lighting fixture manufacturers, which complement the Énergie LLC product offering; LED component manufacturers who own solid intellectual property (IP), and globally recognized consulting firms with experts in the current and future direction of LED technology.
Énergie Holdings, through its wholly owned subsidiary, Energie LLC, received exclusive rights for rapid expansion of distribution in North America from Regent Beleuchtungskörper AG. Energie and Regent (a pioneering Swiss developer of LED energy efficient lighting systems) have been working together for over a decade. Over the past several years, Regent has developed several LED product families targeted at meeting North American LED lighting demands. Énergie’s plan is to launch several of those product families in 2014-2015.
╔nergie Holdings, Inc. (ELED), closed Thursday's trading session at $0.031, up 6.16%, on 453,766 volume with 40 trades. The average volume for the last 60 days is 44,510 and the stock's 52-week low/high is $0.01/$0.25.
Solar3D, Inc. (SLTD)
Stock Analyzer, Market Authority, PennyStocks24, TopPennyStockMovers, Top Stock Picks, and TheMicrocapNews reported on Solar3D, Inc. (SLTD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Solar3D, Inc. is a foremost provider of solar power solutions and the developer of a proprietary high efficiency solar cell. Its technology division is developing a patent-pending three-dimensional solar cell technology to maximize the conversion of sunlight into electricity. The Company has applied for patents covering the innovative three-dimensional solar cell technology. The Solar3D Cell collects sunlight from a wide angle and lets light bounce around in three-dimensional microstructures on the solar cell surface. Solar3D has its corporate office in Santa Barbara, California.
The Company’s mission is to further the extensive adoption of solar power through deploying affordable, state-of-the-art systems and developing innovative new solar technologies. Its solar cell technology employs the three-dimensional design to trap sunlight inside micro-photovoltaic structures where photons bounce around until they undergo conversion into electrons. A unique wide-angle light collection feature on the cell surface allows the collection of sunlight over an assortment of angles during the day.
The design of this next generation solar cell is to be substantially more efficient, with the goal of realizing a lower cost per watt. The expectation is that its three-dimensional technology will combine thin-film and thick-film technologies to achieve the high efficiencies of crystalline at the lower cost of thin film. Solar3D is entering the final phase of the fabrication of the third generation prototype of its new solar cell. It has begun optimizing the elements of its leading-edge solar cell technology to maximize power output.
Solar3D has its SUNworks division. The SUNworks division focuses on the design, installation and management of solar power systems for commercial, agricultural, and residential customers. SUNworks has delivered hundreds of 2.5 kilowatt to 1-megawatt commercial systems and can provide systems as large as 25 megawatts.
Solar3D announced in July 2014 the successful fabrication and operation of the working third generation working prototype of its 3-dimensional silicon solar cell. In August, it announced it is in the process of nationalizing its Patent Cooperation Treaty (PCT) patent application for the production of its proprietary high efficiency solar cell in four strategic countries. These include the U.S., China, Singapore, and India.
Today, Solar3D announced that it signed a definitive purchase agreement to acquire 100 percent of MD Energy, LLC. The purchase is part of Solar3D's growth-by-acquisition strategy, intended to significantly accelerate its top line revenues and its operating earnings. MD Energy is a Rancho Cucamonga, California-based solar systems provider.
Solar3D, Inc. (SLTD), closed Thursday's trading session at $0.21, up 12.30%, on 4,497,469 volume with 492 trades. The average volume for the last 60 days is 3,336,322 and the stock's 52-week low/high is $0.0177/$0.246.
SITO Mobile Ltd. (SITO)
TaglichBrothers, OTCBB Journal, StocksImpossible, and First Penny Picks reported earlier on SITO Mobile Ltd. (SITO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
SITO Mobile Ltd. is a leading mobile media solutions provider that lists on the OTC Bulletin Board. The Company serves businesses, advertisers, as well as brands. The Company's solution (via patented technologies and a user-friendly platform) allows marketers to create content targeted to key audiences, based on location, interests, behaviors, and loyalty. SITO Mobile has its corporate headquarters in Jersey City, New Jersey.
On September 29, 2014, Single Touch Systems, Inc. (SITO), revealed its new name and brand - SITO Mobile. The rebranding follows a period of expansion for the Company throughout the United States and Canada. The new corporate identity underpins SITO Mobile's emphasis on mobile location-based advertising and mobile messaging platforms. These give brands, agencies, and retailers the power to transform digital marketing through delivering targeted mobile advertising campaigns based on geo-location, in-store traffic, and customer response.
Through the increase of mobile devices, SITO Mobile empowers its customers to deliver actionable content in a real-time manner. This drives action and engagement from consumers, while providing vital measurement and analytics, which allow campaigns to be fluid and transaction driven.
Last month, SITO Mobile announced a partnership by which Health Media Network (HMN) will leverage SITO Mobile's mobile media platform to fuel a national location-based advertising network within physician offices nationally. HMN helps to improve the communication between doctor and patient, with the aim of improving healthcare outcomes. HMN will use SITO Mobile's location-based mobile advertising platform as an extension of its existing targeted digital media capabilities. HMN is one of the nation's fastest growing digital Point of Care media enterprises.
The platform presents the opportunity for health marketers to engage with consumers actively discussing treatment options with their doctors. In addition, it offers the ability to reconnect with patients as they travel to the pharmacy or other retailer to fulfill prescriptions, buy OTC (Over-the-Counter) products, and/or interact with the pharmacist.
SITO Mobile Ltd. (SITO), closed Thursday's trading session at $0.31, up 3.33%, on 82,500 volume with 13 trades. The average volume for the last 60 days is 88,140 and the stock's 52-week low/high is $0.2501/$0.695.
Cannabics Pharmaceuticals, Inc. (CNBX)
The QualityStocks Daily Newsletter would like to spotlight Cannabics Pharmaceuticals, Inc. (CNBX). Today, Cannabics Pharmaceuticals, Inc. closed trading at $0.2901, up 7.44%, on 11,457 volume with 8 trades. The stock’s average daily volume over the past 60 days is 8,623, and its 52-week low/high is $0.03/$1.40.
Cannabics Pharmaceuticals, Inc. announced today that it has executed an IP Licensing and Collaboration Agreement with Kalapa Holding (Spain) for the production and distribution of CANNABICS SR medical cannabis products in the Spanish market. Kalapa Holding is a leading medical cannabis and hemp grower and distributor in Spain, with a diverse line of cannabinoid based products.
Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.
Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.
The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.
Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure. Disclaimer
Cannabics Pharmaceuticals, Inc. Company Blog
Cannabics Pharmaceuticals, Inc. News:
Cannabics Pharmaceuticals Signs IP Licensing and Collaboration Agreement in Spain
Cannabics Pharmaceuticals, Inc. (CNBX) Receives Cannabinoid R&D Lab Certification in Israel
Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR
Boreal Water Collection, Inc. (BRWC)
The QualityStocks Daily Newsletter would like to spotlight Boreal Water Collection, Inc. (BRWC). Today, Boreal Water Collection, Inc. closed trading at $0.01, up 85.19%, on 114,424 volume with 9 trades. The stock’s average daily volume over the past 60 days is 871,833, and its 52-week low/high is $0.0032/$0.03.
Boreal Water Collection, Inc. (BRWC) is an established water bottler of premium private-labeled bottled water products tailored for each client’s particular need, be it publicity, promotion, marketing, internal use or a specific event. This emphasis on customization and quality has earned Boreal an impressive reputation, evidenced by its prestigious customer base of high-end beverage brands, retailer channels, high-end hotels and restaurant chains such as H&M, Mercedes, W Hotels, Dean & Deluca, Fred Water, Wat-aah, Saks Fifth Ave, Balance Water, NY Quin Hotel, Bouchon Bakery and Princeton University, just to name a few!
Located 90 miles north New York City, Boreal’s plant is only 17 miles from its well-protected source of natural spring water, a pristine and abundant spring source deep inside the heart of the Catskill Mountains. The spring’s exceptional geological and geographical features have created the perfect environment for Boreal’s low-mineral, sodium-free and well-balanced PH water. With exclusive exploitation rights, Boreal has a confirmed volume in excess of thousands of millions of gallons.
Boreal offers a line of award-winning water products, including functional enhanced water, infused water, carbonated water, vitamins enhanced water, flavored still or sparkling, minerals enhanced water, oxygenated water, electrolyte water, distilled water, alkaline water, caffeinated water and natural spring water.
Accommodating this plentiful water supply and range of product offerings, Boreal has established a 75,000-square foot manufacturing facility. Boreal can process a full range of water and bottle types and has the most creative staff for all private labeling needs. The company offers fully integrated turnkey service, made-to-order labeling along with distinctive water bottles. In short, Boreal is a “Boutique Bottler” and is focusing on becoming the leader of this attractive niche of the growing multi-billion dollar bottled water industry. Disclaimer
Boreal Water Collection, Inc. Company Blog
Boreal Water Collection, Inc. News:
The Chatwal Hotel (NY) Agrees to Have Boreal Water Collection Produce Their Private Labeled Bottled Water
Boreal Water Collection, Inc. Announces Engagement of QualityStocks Investor Relations Services
H&M Group (Manhattan) Signs With Boreal Water Collection
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0053, up 20.45%, on 4,016,570 volume with 28 trades. The stock’s average daily volume over the past 60 days is 1,030,434, and its 52-week low/high is $0.0033/$2.5385.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
The One World Doll Project Announces Financing Relationship With New York Hedge Fund, Blackbridge Capital
One World Holdings, Inc. Announces Engagement of QualityStocks Investor Relations Services
The One World Doll Project Announces New Online Distribution With Toys"R"Us«
Infinite Group, Inc. (IMCI)
The QualityStocks Daily Newsletter would like to spotlight Infinite Group, Inc. (IMCI). Today, Infinite Group, Inc. closed trading at $0.04, up 37.93%, on 1,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 49,717, and its 52-week low/high is $0.021/$0.17.
Infinite Group, Inc. (IMCI) professionals plan, integrate, manage and support complete IT solutions for customers in small to medium-sized businesses, government agencies and large commercial enterprises. Dedicated to quality and customer service, the company’s team of over 80 IT specialists is experienced in their individual fields and maintains the latest certifications. Infinite Group also partners with industry leaders such as VMware, HP, Microsoft, Cisco, and Dell to ensure its customers receive the best combination of products and services designed for their specific needs.
The company’s scalable solutions cover the entire IT chain, including consulting and project management, data storage and recovery solutions, IT security, managed services, and complete IT system development. Providing customers a single point of contact for all their IT needs, Infinite Group helps companies focus on their core business by improving IT efficiencies, reducing capital expenditures, and enjoying significant savings on operational costs.
Based in the Rochester, New York area, the company leverages its deep roots in technology to be one of today’s premier IT service and support suppliers. The company’s IT professionals provide on-site support to customers around the world and serve some of the premiere businesses and government organizations in the United States and worldwide including the U.S. Post Office, PepsiCo, Inc., the State of Mississippi, Home Depot, NASA, PricewaterhouseCoopers, the Florida Department of Financial Services, the U.S. Air Force, Navy, Army, and others. Personnel are located throughout the U.S. including Colorado Springs, Springfield and Vienna, Virginia and Washington, D.C. for added government support.
The IT services industry generates $500 billion in annual revenues and continues to grow as businesses progressively rely on technology to maintain operations and increase efficiency. With decades of experience and technical knowledge, and guided by the highest governance and business conduct guidelines, Infinite Group’s leadership team meets current and future business demands with expertise and effectiveness. Disclaimer
Infinite Group, Inc.Company Blog
Infinite Group, Inc.News:
Infinite Group, Inc. Announces Exclusive Government Channel Partner Agreement for Content Management Tools
Infinite Group, Inc. Partners With Unitrends to Provide Data Protection
Cybersecurity on Infinite Group, Inc.'s Radar With New Hire
Ecrypt Technologies, Inc. (ECRY)
The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.16, up 10.34%, on 30,976 volume with 5 trades. The stock’s average daily volume over the past 60 days is 13,054 and its 52-week low/high is $0.09/$0.179.
Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.
Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.
The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.
Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer
Ecrypt Technologies, Inc. Blog
Ecrypt Technologies, Inc. News:
Ecrypt Technologies, Inc.'s Chief Executive Officer, Dr. Thomas A. Cellucci, Is Elected to Prestigious NCOIC Board
Ecrypt Technologies, Inc. Appoints Urvashi Mehra as VP of Global Healthcare Solutions
Ecrypt Technologies Inc.'s Chief Executive Officer, Dr. Thomas A. Cellucci, is the First American Elected to EECSA's Board
Technology Applications International, Inc. (NUUU)
The QualityStocks Daily Newsletter would like to spotlight Technology Applications International, Inc. (NUUU). Today, Technology Applications International, Inc. closed trading at $1.00, up 11.11%, on 2,550 volume with 5 trades. The stock’s average daily volume over the past 60 days is 2,861, and its 52-week low/high is $0.85/$4.50.
Technology Applications International, Inc. (NUUU) is focused on producing, distributing, marketing and selling skincare products, in addition to engaging in the environmental management and water purification industries. The company conducts its business through two separate wholly owned subsidiaries: Rejuvel Int'l, Inc. and NueEarth, Inc.
Rejuvel Int'l, Inc. developed its skincare line of products using a NASA bioreactor to grow and expand three-dimensional fibroblast cells. Using exclusively licensed technology, licensed from the National Aeronautics and Space Administration and Administrators of the Tulane Educational Fund under U.S. Patent No. 6,730,498, the Rejuvel’s flagship anti-aging facial products trigger the multiplication of human fibroblast skin cells that rebuild skin for a firm, healthy and youthful appearance. The company has been awarded a “seal of approval” from the Space Certification program, setting a new standard for innovation in an industry projected to reach $114 billion in sales by 2015.
NueEarth, Inc. provides environmental management solutions and water purification techniques using a mobile electron beam accelerator unit which creates high-energy electrons that produce free radicals in the wastewater to decompose organic compounds or pollutants. The company has identified a number of different markets for this particle accelerator technology, including the removal of pollutants from wastewater, drinking water, municipal sludge and water that’s contaminated by the fracking process.
Technology Applications International’s management team is methodically establishing its brand in the marketplace with well-respected associations and strategic marketing initiatives. As the company continues to pursue direct consumer sales and other opportunities, it stands to do well with the foundation management has laid for growth. Disclaimer
Technology Applications International, Inc. Company Blog
Technology Applications International, Inc. News:
Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY« Awards Show at the MGM Grand in Las Vegas
Rejuvel Int'l, Inc., a Wholly Owned Subsidiary of NUUU, Announced Today the Signing of a Distribution Agreement with Meditem Cyprus Limited
Rejuvel Int'l, Inc., a Wholly Owned Subsidiary of NUUU, Expands its International Branding Efforts with Placements of Multiple Full Page Print Advertisements in International Fashion and Health Magazines
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.479, up 6.44%, on 542,329 volume with 216 trades. The stock’s average daily volume over the past 60 days is 101,229, and its 52-week low/high is $0.15/$1.00.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
Zenosense, Inc.; MRSA/SA Prototype Achieves over 95% Sensibility in Cultured Headspace
Zenosense, Inc.; Protocol Design -- Lung Cancer Detection Tests
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) Announces Engagement of QualityStocks Investor Relations Services
- Cannabics Pharmaceuticals, Inc. (CNBX) Signs IP Licensing and Collaboration Agreement in Spain
- Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Appoints International Business Professional to Board of Directors
- Ecrypt Technologies, Inc. (ECRY) Chief Executive Officer, Dr. Thomas A. Cellucci, Is Elected to Prestigious NCOIC Board
- Falcon Crest Energy (FCEN) Names Michael Cvetanovic to Advisory Council
- Infinite Group, Inc. (IMCI) Announces Exclusive Government Channel Partner Agreement for Content Management Tools
- Intercept Energy Services, Inc. (IESCF) Annual General Meeting Result
- Mobile Lads Corp. (MOBO) Acquires Innovative Online Coupon Platform, CouBox
- Nhale, Inc. (NHLE) Inks LOI With Oregon Marijuana Grower as Recreational Marijuana Legislation Passes
- One World Holdings, Inc. (OWOO) The One World Doll Project Announces Financing Relationship With New York Hedge Fund, Blackbridge Capital
- Oriens Travel and Hotel Management Corp. (OTHM) and E-Net Kick Off Second Revenue Initiative
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Sibling Group Holdings, Inc. (SIBE) Blended Schools Network Partners With BloomBoard, Inc. for Teacher Professional Development
- Technology Applications International, Inc. (NUUU) Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY« Awards Show at the MGM Grand in Las Vegas
- VistaGen Therapeutics, Inc. (VSTA) Announces Reverse Stock Split
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group
- WRIT Media Group, Inc. (WRIT) Announces Product Updates and NASCAR Event Recap
- Zenosense, Inc. (ZENO) Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device